Division of Research News
UNLV's Division of Research creates a campus environment that supports and promotes superior research, creative, and scholarly pursuits. This ensures that our students and faculty can recognize their full intellectual potential.
Current Research News
Interdisciplinary team will perform computational modeling, experimental design, and develop AI database to identify natural materials for rapid construction in challenging environments.
Report reveals operators and regulators with high ambitions but significant gaps in governance, oversight, and AI maturity.
New Ph.D. graduate Taylor Gerson credits faculty for putting her on the path toward graduate research.
For IGI's community programs manager, the answer is always 'YES' when it comes to supporting career development in youth.
The mergers, measured one month apart in 2024 by LIGO-Virgo-KAGRA collaboration, advance scientific understanding of the nature of black hole formation and fundamental physics; offer evidence of "second-gen" black holes.
Health Physics and Diagnostic Sciences professor brings expertise and cultural pride to UNLV’s new neuroimaging facility.
Research In The News
Nevada forfeits an estimated US$80 million in annual cannabis tax revenue because state regulations impose a 1,500-foot buffer between cannabis retailers and gaming venues, preventing sales in and around the Las Vegas Strip, according to a UNLV Cannabis Policy Institute report published on Thursday.
The findings emerged from the 3rd Annual Gaming & Cannabis Policy Discussion, hosted by the University of Nevada Las Vegas (UNLV) Cannabis Policy Institute and International Gaming Institute. Lawmakers and officials at the event discussed the implications of regulations that prevent the full integration of the licensed cannabis sector with the state’s established gaming industry.
UNLV Cannabis Policy Institute reports state losing tons of money from keeping them separated
According to data from a University of Nevada study, 70% of US adults support allowing cannabis consumption spaces in casinos.
As of two weeks ago, marijuana belonged to the same controlled-substance classification as heroin and LSD. But on April 23, the U.S. Department of Justice reclassified medicinal and FDA-approved cannabis from Schedule I to Schedule III, the group that also includes lower-risk, less-abused drugs such as ketamine and steroids. What does this mean for Nevada’s commercial marijuana industry? That part remains unclear, at least in the short term.
The final rule from the Office of the Attorney General places all drug products that contain marijuana and are federally approved in Schedule III of the Controlled Substances Act. The move shifts cannabis from Schedule I, alongside substances like heroin and LSD, to Schedule III, with the likes of codeine and ketamine.
